Results 31 to 40 of about 376,110 (130)
Biomedicines, 2022 Background: Sepsis is often associated with liver dysfunction, which is an indicator of poor outcomes. Specific diagnostic tools that detect hepatic dysfunction in its early stages are scarce.
Janina Praxenthaler +6 more
doaj +1 more source
Pharmacology Research & Perspectives, 2021 Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including ...
Paul Biever +7 more
doaj +1 more source
Medicina, 2022 Background and Objectives: The hemoadsorption device CytoSorb® (CytoSorbents Inc., Princeton, NJ, USA) has been shown to efficiently remove ticagrelor from whole blood in vitro.
Helmut Mair +7 more
doaj +1 more source
Table1_Impact of CytoSorb® on interleukin-6 in cardiac surgery.pdf
, 2023 ObjectiveCardiac surgery is known to activate a cascade of inflammatory mediators leading to a systemic inflammatory response. Hemadsorption (HA) devices such as CytoSorb® have been postulated to mitigate an overshooting immune response, which is ...
Daniela Geisler (16902909) +15 more
core +1 more source
, 2022 Blutreinigungsverfahren werden in klinischen Studien angewandt, um Patienten unter anderem im septischen Schock zu behandeln. Dabei wird versucht über die Adsorption von Zytokinen und danger associated moleculare patterns (DAMPs) die Funktion der ...
Denzinger, Maximilian Tobias
core +1 more source
Cytokine hemoadsorption with CytoSorb® in post-cardiac arrest syndrome, a pilot randomized controlled trial. [PDF]
Crit Care, 2023 BACKGROUND: Hemoadsorption (HA) might mitigate the systemic inflammatory response associated with post-cardiac arrest syndrome (PCAS) and improve outcomes.
Monard C +7 more
europepmc +2 more sources
Paediatric patient with dengue fever and associated multi-organ dysfunction syndrome (MODS) receiving hemoadsorption using Cytosorb® – A case report on clinical experience [PDF]
International Journal of Medical Device and Adjuvant Treatments, 2020 Objective: Dengue is an arboviral disease, spreads by female aedes mosquito, which has hepatotoxic effects on multiple organ systems. Cytokine extracorporeal hemoadsorption (Cytosorb®) is considered to be a successful adjunctive therapy for adult ...
S. Kumar, S. Damera
doaj +1 more source
Cytosorb® hemoadsorption of apixaban during emergent cardio-pulmonary bypass: a case report.
, 2021 Peri-operative coagulation management of patients receiving apixaban, a new oral anticoagulant, is difficult. The CytoSorb ® hemoadsorption device might represent a therapeutic option to reduce apixaban's pharmacological and inflammatory effects during ...
Mendes, V. +7 more
core +1 more source
Cytosorb® haemoadsorption: a potential game changer for patients needing myocardial surgical revascularisation [PDF]
, 2021 Cytosorb, an extracorporeal blood purification system, utilises the principles of haemoadsorption to remove low molecular weight substances from the blood, including multiple cytokines such as interleukin (IL)-1b, IL-6, IL-8, and tumour necrosis factor-α,
Marczin, Nandor +6 more
core +1 more source
, 2022 Introduction: A group of adult septic shock patients treated with hemoperfusion (HA) with the Cytosorb® associated with CVVHD were studied to determine (a) the effects of this technique on different clinical variables; and (b) the impact of the pre ...
Samola V. +6 more
core +1 more source